Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS)

Christian Faltus(German Cancer Research Center), Angela Risch(German Cancer Research Center)

International Journal of Molecular Sciences

September 14, 2022

10.3390/ijms231810699

Cited by 4

Related Papers

Metabolic gene polymorphism frequencies in control populations.

|PubMed|2001|847

A common coding variant in CASP8 is associated with breast cancer risk

|Nature Genetics|2007|612

Myeloperoxidase G-463A polymorphism and lung cancer: A HuGE Genetic Susceptibility to Environmental Carcinogens pooled analysis

|Genetics in Medicine|2007|52

Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls

|Cancer|2023|8